L1 Recombinant Proteins of HPV Tested for Antibody Forming Using Sera of HPV Quadrivalent Vaccine

키워드

참고문헌 (43)

1. Favre M, "Structural polypeptides of rabbit, bovine, and human papillomaviruses", J Virol, 15, pp.1239~1247 (1975)
2. zur Hausen H, "Viruses in human cancers", Science, 254, pp.1167~1173 (1991)[DOI]
3. Clifford GM, "Human papillomavirus genotype distribution in low-grade cervical lesions: comparison by geographic region and with cervical cancer", Cancer Epidemiol Biomarkers Prev, 14, pp.1157~1164 (2005)[DOI]
4. Burd EM, "Human papillomavirus and cervical cancer", Clin Microbiol Rev, 16, pp.1~17 (2003)[DOI]
5. Munoz N, "Epidemiologic classification of human papillomavirus types associated with cervical cancer", N Engl J Med, 348, pp.518~527 (2003)[DOI]
6. Greer CE, "Human papillomavirus (HPV) type distribution and serological response to HPV type 6 virus-like particles in patients with genital warts", J Clin Microbiol, 33, pp.2058~2063 (1995)
7. Clifford GM, "Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: a meta-analysis", Br J Cancer, 89, pp.101~105 (2003)[DOI]
8. Harper DM, "Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial", Lancet, 364, pp.1757~1765 (2004)[DOI]
9. Volpers C, "Assembly of the major and the minor capsid protein of human papillomavirus type 33 into virus-like particles and tubular structures in insect cells", Virology, 200, pp.504~512 (1994)[DOI]
10. Schiller JT, "Papillomavirus-like particle vaccines for cervical cancer", Mol Med Today, 5, pp.209~215 (1999)
11. Kirnbauer R, "Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic", Proc Natl Acad Sci U S A, 89, pp.12180~12184 (1992)[DOI]
12. Roden RB, "In vitro generation and type-specific neutralization of a human papillomavirus type 16 virion pseudotype", J Virol, 70, pp.5875~5883 (1996)
13. Unckell F, "Generation and neutralization of pseudovirions of human papillomavirus type 33", J Virol, 71, pp.2934~2939 (1997)
14. White WI, "In vitro infection and type-restricted antibody-mediated neutralization of authentic human papillomavirus type 16", J Virol, 72, pp.959~964 (1998)
15. Doorbar J, "Identification of proteins encoded by the L1 and L2 open reading frames of human papillomavirus 1a", J Virol, 61, pp.2793~2799 (1987)
16. Zhou J, "Expression of vaccinia recombinant HPV 16 L1 and L2 ORF proteins in epithelial cells is sufficient for assembly of HPV virion-like particles", Virology, 185, pp.251~257 (1991)[DOI]
17. Rose RC, "Expression of human papillomavirus type 11 L1 protein in insect cells: in vivo and in vitro assembly of viruslike particles", J Virol, 67, pp.1936~1944 (1993)
18. Sasagawa T, "Synthesis and assembly of virus-like particles of human papillomaviruses type 6 and type 16 in fission yeast Schizosaccharomyces pombe", Virology, 206, pp.126~135 (1995)[DOI]
19. Nardelli-Haefliger D, "Human papillomavirus type 16 virus-like particles expressed in attenuated Salmonella typhimurium elicit mucosal and systemic neutralizing antibodies in mice", Infect Immun, 65, pp.3328~3336 (1997)
20. Cho HJ, "Induction of mucosal and systemic immune responses following oral immunization of mice with Lactococcus lactis expressing human papillomavirus type 16 L1", Vaccine, 25, pp.8049~8057 (2007)[DOI]
21. Palker TJ, "Antibody, cytokine and cytotoxic T lymphocyte responses in chimpanzees immunized with human papillomavirus virus-like particles", Vaccine, 19, pp.3733~3743 (2001)[DOI]
22. Dias D, "Optimization and validation of a multiplexed luminex assay to quantify antibodies to neutralizing epitopes on human papillomaviruses 6, 11, 16, and 18", Clin Diagn Lab Immunol, 12, pp.959~969 (2005)
23. Kirnbauer R, "A virus-like particle enzyme-linked immunosorbent assay detects serum antibodies in a majority of women infected with human papillomavirus type 16", J Natl Cancer Inst, 86, pp.494~499 (1994)[DOI]
24. Opalka D, "Simultaneous quantitation of antibodies to neutralizing epitopes on virus-like particles for human papillomavirus types 6, 11, 16, and 18 by a multiplexed luminex assay", Clin Diagn Lab Immunol, 10, pp.108~115 (2003)
25. Christensen ND, "Surface conformational and linear epitopes on HPV-16 and HPV-18 L1 virus-like particles as defined by monoclonal antibodies", Virology, 223, pp.174~184 (1996)[DOI]
26. Christensen ND, "Monoclonal antibodies to HPV-6 L1 virus-like particles identify conformational and linear neutralizing epitopes on HPV-11 in addition to type-specific epitopes on HPV-6", Virology, 224, pp.477~486 (1996)[DOI]
27. Sehr P, "HPV antibody detection by ELISA with capsid protein L1 fused to glutathione S-transferase", J Virol Methods, 106, pp.61~70 (2002)[DOI]
28. Harper DM, "Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial", Lancet, 367, pp.1247~1255 (2006)[DOI]
29. Zhang W, "Expression of human papillomavirus type 16 L1 protein in Escherichia coli: denaturation, renaturation, and self-assembly of virus-like particles in vitro", Virology, 243, pp.423~431 (1998)[DOI]
30. 김은혜, "Species Specific Antiviral Activity of Porcine Interferon-α8 (IFNα8)", Immune Network, 17(6), pp.424~436 (2017), 대한면역학회[DOI]
31. Areum Kwak, "Intracellular interleukin (IL)-1 family cytokine processing enzyme", Archives of Pharmacal Research, 39(11), pp.1556~1564 (2016), 대한약학회
32. 이시영, "IL-32-induced Inflammatory Cytokines Are Selectively Suppressed by a1-antitrypsin in Mouse Bone Marrow Cells", Immune Network, 17(2), pp.116~120 (2017), 대한면역학회[DOI]
33. Lee S, "Proinsulin shares a motif with interleukin-<TEX>$1{\alpha}$<", TEX> (IL-<TEX>$1{\alpha}$<, J Biol Chem, pp.2016, 291[DOI]
34. 김현우, "Cytokine-like Activity of Liver Type Fatty Acid Binding Protein (L-FABP) Inducing Inflammatory Cytokine Interleukin-6", Immune Network, 16(5), pp.296~304 (2016), 대한면역학회[DOI]
35. Jo S, "Reconstitution of ST2 (IL-1R4) specific for IL-33 activity; no suppression by IL-1Ra though a common chain IL-1R3 (IL-1RAcP) shared with IL-1", Cytokine, 83, pp.33~40 (2016)[DOI]
36. Kim B, "The interleukin-<TEX>$1{\alpha}$<", TEX> precursor is biologically active and is likely a key alarmin in the IL-1 family of cytokines, 2013, pp.4, 391~
37. Hong SN, "Clinical characteristics and the expression profiles of inflammatory cytokines", cytokine regulatory factors in asymptomatic patients with nodular gastritis, 2012, pp.57, 1486~1495
38. Bae S, "The contradictory functions (activation", termination) of neutrophil proteinase 3 (PR3) in IL-33 biological activity, 2012, pp.287, 8205~8213
39. Ma Z, "Increasing the expression levels of papillomavirus major capsid protein in Escherichia coli by N-terminal deletion", Protein Expr Purif, 56, pp.72~79 (2007)[DOI]
40. Waterboer T, "Multiplex human papillomavirus serology based on in situ-purified glutathione S-transferase fusion proteins", Clin Chem, 51, pp.1845~1853 (2005)[DOI]
41. Dessy FJ, "Correlation between direct ELISA, single epitope-based inhibition ELISA and pseudovirion-based neutralization assay for measuring anti-HPV-16 and anti-HPV-18 antibody response after vaccination with the AS04-adjuvanted HPV-16", 18 cervical cancer vaccine, 2008, pp.4, 425~434
42. Einstein MH, "Comparison of the immunogenicity and safety of Cervarix and Gardasil human papillomavirus (HPV) cervical cancer vaccines in healthy women aged 18-45 years", Hum Vaccin, 5, pp.705~719 (2009)[DOI]
43. Hernandez BY, "Human papillomavirus (HPV) L1 and L1-L2 virus-like particle-based multiplex assays for measurement of HPV virion antibodies", Clin Vaccine Immunol, 19, pp.1348~1352 (2012)[DOI]

관련 논문AI추천